GPBAR1 and Alzheimer disease: Neuroprotective and anti-inflammatory effects via microglial TGR5 activation; potential benefits in neurodegenerative disease models. Improves glucose homeostasis, influences appetite via CNS gut–brain axis, potential therapeutic target for Alzheimer’s disease.